Now here’s a recipe for success. A porous, manmade bone replacement plus bioactive medication plus a little knowledge about stem cell research equals a 96% improvement in bone-to-implant connection. Researchers including Jeremy Mao at the Columbia College of Dental Medicine made this finding, which was reported in The Journal of the Federation of American Societies for Experimental Biology this month. Only one-tenth of the normal dose of bioactive medication is required for these results, and this is an important finding.
Learn more about the specifics of Mao’s research and how it could lead to great advances in the human body’s acceptance of manmade materials, such as dental implants and cardiac stints, here.
"The research was supported by U.S. National Institutes of Health grants DE015391 and EB02332 to Mao and his colleagues. Mao, D.D.S., Ph.D. is a dentist, a tissue engineer and professor at the Columbia University College of Dental Medicine," per Medical News Today.